GST NO. : 27AEZFS4094K1ZY
| Business Type | Exporter, Supplier, Trader |
| Strength | 100mg |
| Dosage Form | Intravenous Injection |
| Type | Chemotherapy Drug |
| Click to view more | |
Product Details
Certification
WHO-GMP Certified
Packaging
Box
Packaging Size
10ml
Manufacturer
Pfizer Ltd
Active Ingredient
Cytarabine
Indicated For
AML, ALL, CML, And Other Leukemias
Patient Benefits
Effective Chemotherapy Agent For Blood Cancers
Product Description
- Indicated For: AML, ALL, CML, and other leukemias
- Active Ingredient: Cytarabine 1000mg
- Mechanism of Action: Inhibits DNA synthesis, preventing cancer cell growth
- Dosage Form: Intravenous injection (1 vial per pack)
- Manufactured By: Pfizer Ltd (WHO-GMP certified)
- Patient Benefits: Effective chemotherapy agent for blood cancers
- Medical Supervision Required: Administered by healthcare professionals
- Cytosar 1000mg Injection contains Cytarabine (1000mg), a chemotherapy drug used in the treatment of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML). It works by interfering with the growth of cancer cells, slowing or stopping their spread in the body. Manufactured by Pfizer Ltd, Cytosar 1000mg is administered via intravenous (IV) injection under medical supervision. It is a crucial part of chemotherapy regimens and is often combined with other anti-cancer medications. Patients should be monitored for side effects, and dosage should be tailored based on medical advice.
Looking for "Cytosar 100mg Cytarabine Injection" ?
Box
